摘要
目的研讨十二指肠溃疡出血患者使用注射用兰索拉唑治疗的临床价值。方法选取我院消化内科2015年6月至2018年6月收治的82例十二指肠溃疡出血患者作为观察对象,经随机抽签方式分两组,对照组(n=41)接受注射用奥美拉唑钠治疗,实验组(n=41)接受注射用兰索拉唑治疗,对两组注射药物的药效、止血率等指标进行比较与评估。结果两组在临床药效的对比上相当,无统计学意义(P>0.05),实验组止血率为100.0%,平均止血时间为(23.53±6.15)h,与对照组的止血率95.1%与止血时间(24.08±5.72)h比较,无统计学意义(P>0.05)。结论对十二指肠溃疡出血患者实施注射用兰索拉唑治疗,药效显著、止血时间快,值得推荐。
Objective To study the clinical value of Lansoprazole for injection in the treatment of duodenal ulcer bleeding. Methods Eighty-two patients with duodenal ulcer bleeding admitted to our hospital from June 2015 to June2018 were randomLy divided into two groups. The control group(n=41) received omeprazole sodium for injection and the experimental group(n=41) received Lansoprazole for injection. The pharmacodynamics and hemostasis rate of the two groups were compared and evaluated. Results There was no significant difference in clinical efficacy between the two groups(P>0.05). The hemostasis rate of the experimental group was 100.0%, and the average hemostasis time was(23.53±6.15) h. There was no significant difference between the two groups in the hemostasis rate of 95.1% and that of the control group(24.08±5.72) h(P>0.05). Conclusion Lansoprazole for injection in patients with duodenal ulcer hemorrhage has remarkable efficacy and quick hemostasis time, which is worthy of recommendation.
作者
陈岩
CHEN Yan(Helong People’s Hospital,Helong,Jilin 133500)
出处
《智慧健康》
2019年第8期96-97,共2页
Smart Healthcare